a public good project by the
Synthesis
Company
of California

© 2026

Hans W. Nijman | doi.page

0 works0 citations0 h-index

Hans W. Nijman

University Medical Center Groningen(NL)University Medical Center Groningen(NL)University of Groningen(NL)

Publications by Year

Research Areas

Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cervical Cancer and HPV Research

Most-Cited Works

→ B lymphocytes secrete antigen-presenting vesicles.(1996)3,443 cited
→ ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up(2015)1,359 cited
→ The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis(2011)1,279 cited
→ Tumor-infiltrating lymphocytes in the immunotherapy era(2020)898 cited
→ Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts(2016)833 cited
→ Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy(2020)790 cited

→ Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial(2018)

604 cited

→ Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative(2015)481 cited

→ Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial(2019)438 cited

→ Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer(2008)397 cited